AGP Executive Report
Last update: 8 hours agoFederal Policy: State cannabis regulators are pressing the DEA for guidance on rescheduling, while looming federal THC restrictions put hemp businesses on alert. Medical Access: New Jersey signed reforms to expand its medicinal cannabis program, and New York regulators approved a trial of oral THC for sciatica-related pain. The FDA also cleared a pathway for conditional approval of a cannabinoid drug for canine bone-cancer pain. CBD Research: The University of Regina is studying CBD as a possible concussion treatment. Industry Oversight: Florida entered a consent order with Trulieve over wastewater discharges at its Monticello cultivation site.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.